1. Home
  2. ENR vs MESO Comparison

ENR vs MESO Comparison

Compare ENR & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energizer Holdings Inc.

ENR

Energizer Holdings Inc.

HOLD

Current Price

$20.21

Market Cap

1.7B

Sector

Miscellaneous

ML Signal

HOLD

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$19.00

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENR
MESO
Founded
2015
2004
Country
United States
Australia
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ENR
MESO
Price
$20.21
$19.00
Analyst Decision
Hold
Strong Buy
Analyst Count
7
2
Target Price
$27.00
$24.00
AVG Volume (30 Days)
1.3M
230.2K
Earning Date
02-03-2026
08-28-2025
Dividend Yield
5.91%
N/A
EPS Growth
538.46
N/A
EPS
3.32
N/A
Revenue
$2,952,700,000.00
$17,198,000.00
Revenue This Year
$2.65
$576.59
Revenue Next Year
$1.09
$41.15
P/E Ratio
$6.12
N/A
Revenue Growth
2.28
191.39
52 Week Low
$16.77
$9.61
52 Week High
$35.90
$22.00

Technical Indicators

Market Signals
Indicator
ENR
MESO
Relative Strength Index (RSI) 50.77 59.33
Support Level $19.55 $19.00
Resistance Level $21.34 $19.60
Average True Range (ATR) 0.81 0.55
MACD 0.24 0.04
Stochastic Oscillator 68.21 62.38

Price Performance

Historical Comparison
ENR
MESO

About ENR Energizer Holdings Inc.

Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

Share on Social Networks: